Mahboobifard et al. asserted that the pathway underlying PRL elevation in PCOS might be attributed to a decline in central dopaminergic tone associated with PCOS, which leads to an increase in levels of PRL. The gene discussed is PRL; the disease is polycystic ovary syndrome.